Saventic

Healthcare struggles to diagnose rare diseases
• Up to 10% of population faces rare diseases, there are more than 6.000 rare diseases, many undiscovered, many without treatment
• Only 1 in 8 patients with rare diseases is diagnosed & duly treated, many patients remain undiagnosed or misdiagnosed
• Current screening/diagnosing methods reached plateau of efficacy
• IT systems are filled with data that is difficult to access & use

Saventic provides AI based diagnosis solutions
• Developed technology to diagnose rare diseases early based on:
– (i ) artificial intelligence,
–(ii) blood test results and
–(iii) medical records (EHR)
• Executes pattern analysis of medical data to support physicians,patients, and stakeholders

Commercial proposition
For medical providers / insurers to decrease the diagnostic costs (shorten patients’ pathways), limit the risk of oversight, misdiagnosis, potential lawsuits
• For pharmaceutical industry to support patients’ diagnosis / identification for treatment or clinical trials

• Commercial proposition For medical providers / insurers to decrease the diagnostic costs (shorten patients’ pathways), limit the risk of oversight, misdiagnosis, potential lawsuits
•For pharmaceutical industry to support patients’ diagnosis / identification for treatment or clinical trials